ENVA Enova International, Inc. Insider Trading

Executive Chairman David Fisher sells 28,500 ENVA shares ($6.6M) via scheduled 10b5-1 plan; retains 306,444 non-derivative shares plus 380,858 options

David Fisher executed 2 separate scheduled sales totaling 28,500 shares for $6,597,325.02 at a blended average price of $231.49 under a pre-arranged 10b5-1 trading plan, reducing his non-derivative holding from 334,944 to 306,444 shares. This represents a reduction of 8.5% of pre-transaction non-derivative holdings, though Fisher retains 380,858 derivative shares (Non-Qualified Stock Options) that constitute his material remaining position at the company. The sales occurred against a backdrop of strong recent momentum—the stock has advanced 21.5% over 30 days and 44.7% over 90 days—and solid fundamentals including $875.1M quarterly revenue, $91.1M net income, and 18.6% annual revenue growth. As a scheduled transaction under 10b5-1, the timing was predetermined rather than discretionary, and Fisher's cross-ticker track record shows 20 prior sells with an average 90-day return of 6.7%, while his ENVA-specific prior 4 measurable sales have posted mixed results ranging from -9.7% to +27.8% over 30 days.

Director Mark Tebbe sells 20,000 ENVA shares for $4.0M amid 49% 90-day rally; 100% track record of well-timed sells.

Mark Tebbe (Director) sold 20,000 shares (28.6% of pre-transaction holdings) at $201.37 on 2026-06-18, realizing $4,027,360. The sale occurs after ENVA stock rallied 49% over 90 days and now sits within 0.7% of its 52-week high ($206.19). Critically, Tebbe's cross-ticker track record shows a 100.00% well-timed rate on his 1 prior sell—he previously exited before subsequent declines—and his same-ticker history at ENVA (1 prior trade: a sell on 2026-02-02) also exhibited the same negative 90-day return pattern (-0.8%), indicating consistent timing discipline. Post-transaction, Tebbe retains 50,029 shares. The company shows strong fundamentals: $875.1M quarterly revenue, $91.1M net income, +18.6% annual revenue growth, and P/E of 15.61. The question for investors is whether the insider's historical ability to exit before declines carries predictive weight in a company trading near peak valuation after a steep run.

ENVA: David Fisher (Executive Chairman) sold 33,060 shares at $199.05 under 10b5-1 plan; $6.6M transaction

David Fisher, Executive Chairman of Enova International, sold 33,060 shares (33.1K shares) for $6,580,639.28 ($6.6M) on 2026-06-17 as part of a pre-arranged 10b5-1 trading plan, leaving him with 306,444 non-derivative shares and 213,182 option holdings. The sale reduced his non-derivative holdings by 9.7% but occurred when the stock was at $199.05, near its 52-week high of $206.19 (-0.7%) and up +30.0% over 30 days and +49.0% over 90 days. His prior five trades at ENVA show mixed near-term results: two recent sells (2026-05-22 and 2026-05-21) were followed by +27.8% and +26.3% 30-day gains respectively, while earlier sells returned negative 30-day results, though longer-term outcomes at this ticker have been measurable in only two instances (one showing +7.5% 90-day gain, one showing +2.5%). Because this is a scheduled 10b5-1 transaction, the timing reflects plan mechanics rather than discretionary judgment; the stock's proximity to its 52-week high and strong recent momentum provide context but do not alter the nature of the trade as pre-arranged.

ENVA: Exec Chairman Fisher sells 10,256 shares for $1.6M via scheduled 10b5-1 plan

David Fisher, Executive Chairman of Enova International, Inc., executed 2 separate sales totaling 10,256 shares for $1,638,855.88 at blended average price $159.79 on May 21–22, 2026, pursuant to a pre-arranged 10b5-1 trading plan. This represents a scheduled transaction, not a discretionary decision. Post-transaction, Fisher holds 306,444 shares in non-derivative form, alongside derivative holdings of 249,318 shares (Non-Qualified Stock Option with limited SAR) and 246,242 shares (Non-Qualified Stock Option with limited SAR), indicating a substantial ongoing position in the company. At $159.05 current price, the stock is -10.0% from its 52-week high of $176.68 and -4.6% over the trailing 30 days, while ENVA's fundamentals remain solid: revenue of $875,142,000.00, net income of $91,099,000.00, annual revenue growth of +18.6%, and a P/E of 12.12. The transaction's scheduled nature and Fisher's retention of meaningful derivative and direct holdings provide limited insight into management conviction regarding near-term valuation.

Director William M Goodyear sold 6,231 shares of ENVA at $166.08 for $1,034,829.53

Director William M Goodyear sold 6,231 shares at $166.08 on 2026-05-18, reducing his holdings from 74,971 shares to 68,740 shares. The transaction value of $1,034,829.53 represents an 8.3% reduction in his pre-transaction holdings. At the current price of $164.59, the stock is trading 6.8% below its 52-week high of $176.68, while the company reports strong fundamentals with annual revenue growth of 18.6%, net income of $91,099,000.00, and a P/E of 12.54. The sale occurs in a context where the stock has risen 13.5% over the past 90 days, following a modest 0.4% decline over the past 30 days.

Executive Chairman David Fisher sells 20,000 ENVA shares for $3.5M; repeat seller with mixed timing on prior exits at this stock.

Executive Chairman David Fisher sold a significant block of Enova shares on 2026-05-07, reducing his holdings by over 6 percent. This is Fisher's 32nd open-market sale in the past three years—he has never purchased shares on the open market, establishing a pure seller profile throughout his tenure. At the 30-day horizon, Fisher's prior five exits at this stock show strong timing, with four of those sales preceding price declines; however, over a 90-day window the pattern reverses, with only one of those five prior sales proving well-timed and the other four followed by gains Fisher missed. This conflicting short-term vs. long-term timing record makes it difficult to read conviction from the current sale. Enova itself is financially healthy—a profitable company with growing revenues and a reasonable valuation—so this transaction appears to be portfolio management rather than a distress sale. The stock currently trades at its 52-week high, which is an unusually strong price point for an insider seller; most insider selling occurs during weakness.

CEO Cunningham sells 7,852 ENVA shares for $1,378,026.00 total; holds 122,945 shares post-transaction

Steven E. Cunningham, Chief Executive Officer of Enova International, executed two separate sales on 2026-04-28 totaling 7,852 shares for $1,378,026.00 at $175.50 per share, reducing his holdings to 122,945 shares (a -6.0% reduction). The transaction occurred near the 52-week high of $173.60, with the current price at $169.41 representing a -2.4% pullback from that peak. Enova's fundamentals remain solid with Revenue of $875,142,000.00, Net income of $91,099,000.00, annual revenue growth of +18.6%, and a P/E of 12.91, providing no immediate distress signal. Notably, Cunningham's prior sales at ENVA have not demonstrated favorable timing: 0 of 5 prior sells were well-timed at the 90-day mark, with 4 of 5 showing positive 90-day returns (meaning the stock rose after his sales), suggesting this CEO has historically sold before subsequent gains rather than declines.

Executive Chairman Fisher David sold 7,143 ENVA shares at $149.49 for $1.1M on 2026-02-18; retains 326.4K shares.

Fisher David, Executive Chairman of Enova International (ENVA), sold 7,143 shares at $149.49 on 2026-02-18, reducing his holdings by -2.1% while retaining 326.4K shares post-transaction. The sale occurred during a period of recent weakness: the stock is down 8.1% over the past 30 days and -15.7% from its 52-week high of $172.37, though it is up 17.0% over 90 days. At ENVA specifically, Fisher's prior two sales (on 2026-01-30 and 2026-01-26) outcomes are not yet measurable, while his earlier ENVA sales showed mixed results—the 2025-10-27 sale followed by 28.5% 90-day appreciation and the 2025-11-21 sale followed by 16.7% 90-day appreciation. His cross-ticker track record across 20 prior sales shows an average 90-day return of +9.0% with a well-timed rate of 35.29%, indicating his sells have historically missed gains more often than they have preceded declines. The underlying business remains solid with a P/E of 9.27, 18.6% annual revenue growth, and 80.3M in net income on 802.7M revenue.

Director Mark Tebbe sold entire 20,000-share ENVA holding for $3.4M at $172.24, liquidating position completely.

Mark Tebbe, a Director of Enova International, liquidated his complete shareholding of 20,000 shares in a single transaction on 2026-02-02 for $3,444,824.00, eliminating all equity stake in the company. The sale occurred near the 52-week high of $172.37, with current price of $155.72 representing a 9.7% decline from that peak. This complete exit by a board-level insider stands out given the company's strong operational fundamentals: $802.7M in latest quarterly revenue with 25.5% annual growth, net income of $80.3M, and a valuation of $3.9B market cap at a moderate 13.17 P/E ratio. The elimination of all director holdings warrants investor attention to understand the motivation and whether this signals a change in Tebbe's confidence in the company's direction or outlook.

Director Gray James A sold 19,999 shares of ENVA for $3.4M, reducing stake by 66.7% to 10.0K shares

Director Gray James A executed 2 separate sales totaling 19,999 shares for $3,440,628.78 on 2026-02-02, with per-transaction prices of $171.86 and $172.22 and a blended average price of $172.04. This sale reduced his holdings from 30,000 shares to 10,001 shares, representing a 66.7% reduction in his position. The transactions occurred when ENVA's stock was trading near its 52-week high of $172.37, and the current price of $155.72 is now 9.7% below that peak, indicating the insider sold at valuations materially above current levels. Against a backdrop of strong fundamentals—25.5% annual revenue growth, a P/E of 13.17, and quarterly net income of $80.3M—this substantial reduction in the director's ownership stake provides context that warrant investor attention regarding the insider's forward expectations.